Back
Prime Medicine, Inc. 10K Form
Sell
32
PRME
Prime Medicine, Inc.
Last Price:
$3.62
Seasonality Move:
-21.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PRME News And Ratings
See the #1 stock for the next 7 days that we like better than PRME
PRME Financial Statistics
Sales & Book Value
| Annual Sales: | $3M |
|---|---|
| Cash Flow: | $-35.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.90 |
| Price / Book: | 4.06 |
Profitability
| EPS (TTM): | -1.47530 |
|---|---|
| Net Income (TTM): | $-197.3M |
| Gross Margin: | $-3.1M |
| Return on Equity: | -146.77% |
| Return on Assets: | -54.36% |
Prime Medicine, Inc. Earnings Forecast
Key Prime Medicine, Inc. Financial Ratios
-
The Gross Profit Margin over the past 6 years for PRME is -105.43%.
-
The Selling, General & Administrative Expenses for PRME have been equal to 1,681.56% of Gross Profit Margin.
-
The Research & Development expenses have been 5,205.80% of Revenue.
-
The Net Earning history of PRME is -6,566.61% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Prime Medicine, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PRME |
| Website: | primemedicine.com |
Debt
| Debt-to-Equity Ratio: | 0.73 |
|---|---|
| Current Ratio: | 6.61 |
| Quick Ratio: | 6.09 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PRME Technical Analysis vs Fundamental Analysis
Sell
32
Prime Medicine, Inc. (PRME)
is a Sell
Is Prime Medicine, Inc. a Buy or a Sell?
-
Prime Medicine, Inc. stock is rated a SellThe current Prime Medicine, Inc. [PRME] share price is $3.64. The Score for PRME is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.